Docetaxel/Carboplatin

DRUG2 trials

Sponsors

SCRI Development Innovations, LLC, Shanghai Jiao Tong University School of Medicine

Conditions

Non-Small Cell Lung CancerRecurrent Non-small Cell Lung Cancer

Phase 1

A Randomised Trial of Chemotherapy Plus Surgery for Recurrent Non-Small Cell Lung Cancer

RecruitingNCT02889666

Shanghai Jiao Tong University School of MedicineRecurrent Non-small Cell Lung Cancer

Start: 2008-01-31End: 2027-12-31Target: 500Updated: 2024-04-17

Phase 2

Carboplatin, Docetaxel, Bevacizumab, and Erlotinib Versus Chemotherapy Alone in Resected NSCLC

CompletedNCT00621049

SCRI Development Innovations, LLCNon-Small Cell Lung Cancer

Start: 2007-12-31End: 2014-02-28Updated: 2015-06-08